NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/11/2025
Voltar para busca
Dado oficial do USPTO
GENFIT TOWARDS BETTER MEDICINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
08/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
09/05/2016
Data de registro
23/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/11/2025
Última transação
08/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
99
Localização do titular
Loos, FR
Examinador
BELENKER, ESTHER
Localização atual
Historical data usage
Descrição da marca
The mark consists of of the word "GENFIT" in blue, the words "TOWARDS BETTER MEDICINE" in orange; and a sphere in orange and blue and slanted lines on the sphere in white.
Titulares e representantes
Titulares
GENFIT
Representantes
Ronald M. Kachmarik Cooper Legal Group LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalveterinary preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary system; pharmaceutical and veterinary preparations for the treatment of inflammatory disorders; pharmaceutical and veterinary preparations for use in dermatologyin the prevention and treatment of cancersin the treatment of infectious diseases of the blood and in tissue and organ transplantationin the treatment of eye diseases and conditions and for gastroenterological disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for preventing and treating sunburn; slimming medical preparations; cultures of microorganism for medical or veterinary use; culture media for cultivating microorganism; nutritive substances for microorganisms for medical purposescells for medicalclinical or veterinary use; pharmaceutical and veterinary compounds for human or animal use to treat metabolic disorderscardiovascular diseasesdermatological diseasesdisorders in the central nervous systemcancersasthmaallergieslipid disordersobesity and diabetes; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; and food supplements for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/07/2025
E815
TEAS SECTION 8 & 15 RECEIVED
17/07/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2019
PUBO
PUBLISHED FOR OPPOSITION
07/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2019
RPUB
NOA CANCELLED; REPUBLICATION REQUIRED
02/04/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2019
PBIU
WITHDRAWN FROM PUB-ITU REQUEST
01/04/2019
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
26/03/2019
APET
ASSIGNED TO PETITION STAFF
25/03/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/03/2019
IUCN
NOTICE OF ALLOWANCE CANCELLED
13/03/2019
EX3G
SOU EXTENSION 3 GRANTED
13/03/2019
EXT3
SOU EXTENSION 3 FILED
13/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
13/03/2019
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
13/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/09/2018
EX2G
SOU EXTENSION 2 GRANTED
26/09/2018
EXT2
SOU EXTENSION 2 FILED
26/09/2018
EEXT
SOU TEAS EXTENSION RECEIVED
26/09/2018
DOCK
ASSIGNED TO EXAMINER
10/08/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/03/2018
EX1G
SOU EXTENSION 1 GRANTED
26/03/2018
EXT1
SOU EXTENSION 1 FILED
26/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
26/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2017
PUBO
PUBLISHED FOR OPPOSITION
01/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/06/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
21/06/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/06/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
21/06/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/06/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/06/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
20/06/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/06/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2017
GNRT
NON-FINAL ACTION E-MAILED
06/03/2017
CNRT
NON-FINAL ACTION WRITTEN
06/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2017
ALIE
ASSIGNED TO LIE
26/02/2017
ALIE
ASSIGNED TO LIE
12/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/08/2016
GNRT
NON-FINAL ACTION E-MAILED
24/08/2016
CNRT
NON-FINAL ACTION WRITTEN
24/08/2016
DOCK
ASSIGNED TO EXAMINER
24/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
13/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2016
NWAP
NEW APPLICATION ENTERED
12/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENFIT TOWARDS BETTER MEDICINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.